Airani Sathananthan is an Endocrinology/Metabolic physician affiliated with Clinical Trial Investigators. OpenAlex indexes 43 publications with 1,440 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
795 E 2nd St
Suite 4
Pomona, CA 917662007
Telephone
909-706-3779Registry record last updated 13 Jun 2017.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20254 payments
- Lilly USA, LLCProgram year20251 payment
- Xeris Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
86.2%GLP-1 receptor agonist31.3%Ozempic40%Trulicity37%Mounjaro23%Part D<11 patientsInsulin Analog27.2%Lantus Solostar32%Basaglar Kwikpen U-10022%Humalog Kwikpen U-10014%Novolog Flexpen10%Toujeo Max Solostar7%Admelog Solostar6%Toujeo Solostar5%Insulin Aspart Flexpen5%Part D<11 patients+ 4 more classes in this area
Hormonal (systemic)
8.8%l-Thyroxine6.9%Levothyroxine Sodium100%Part D≥17 patientsThyroid Hormone Synthesis Inhibitor1.9%Methimazole100%Part D<11 patientsCardiovascular
5%Statin3.1%Atorvastatin Calcium100%Part D≥13 patientsACE inhibitor1.9%Lisinopril100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacokinetics comparison of vardenafil as administered by an intranasal spray formulation vs a 10-mg oral tablet
The Journal of Sexual Medicine
2023 - A Patient with Addison Disease (Primary Adrenal Insufficiency) Presenting for Surgical Extraction of Third Molars
Dental Clinics of North America
2023 - Dental Considerations and Precautions Associated with Oral Excisional Biopsy on a Patient with Cushing’s Syndrome (Hypercortisolism)
Dental Clinics of North America
2023 - Implant Placement in a Patient with Thyromegaly Associated with Graves Disease
Dental Clinics of North America
2023
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”